Skip to main content

Pancreatic Polypeptide and Glucose Metabolism

  • Chapter

Part of the book series: Contemporary Endocrinology ((COE,volume 8))

Abstract

Pancreatic polypeptide (PP) has been scrutinized as a potential metabolic regulatory substance since its discovery. Data are now emerging that indicates PP has effects on insulin action and carbohydrate metabolism, which may be of great physiologic importance. The demonstration of such effects has been difficult despite characteristics that have invited the belief that this peptide might be a glucoregulator, namely its presence in pancreatic islets along with other substances with well-known glucoregulatory effects, and its postprandial pattern of release. Despite these characteristics, the physiologic role of PP was initially thought to involve actions such as inhibition of choleresis and exocrine pancreatic secretion through indirect effects on central and peripheral nerve fibers (1,2).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jung G, Louie DS, Owyang C (1987) Pancreatic polypeptide inhibits pancreatic enzyme secretion via a cholinergic pathway. Am J Physiol 235: G706 - G10.

    Google Scholar 

  2. Putnam WS, Liddle RA, Williams JA (1989) Inhibitory regulation of rat exocrine pancreas by peptide YY and pancreatic polypeptide. Am J Physiol 256: G698 - G703.

    PubMed  CAS  Google Scholar 

  3. Berger D, Crowther RC, Floyd JC, Pek S, Fajans SS (1978) Effect of age on fasting plasma levels of pancreatic hormones in man. J Clin Endocrinol Metab 47: 1183–1189.

    Article  PubMed  CAS  Google Scholar 

  4. Floyd JC Jr, Fajans SS, Pek S, Chance RE (1976) A newly-recognized pancreatic polypeptide; plasma levels in health and disease. Recent Prog Horm Res 33: 519–570.

    PubMed  CAS  Google Scholar 

  5. Williams RH, Champagne J (1979) Effects of cholecystokinin, secretin and pancreatic polypeptide on secretion of gastric inhibitory polypeptide, insulin and glucagon. Life Sci 25: 947–956.

    Article  PubMed  CAS  Google Scholar 

  6. Lundquist I, Sundler F, Ahren B, Alumets J, Hakanson R (1979) Somatostatin, pancreatic polypeptide, substance P and neurotensin: cellular distribution, and effects on stimulated insulin secretion in the mouse. Endocrinology 104: 832–838.

    Article  PubMed  CAS  Google Scholar 

  7. Murphy WA, Fries JL, Meyers CA, Coy DH (1981) Human pancreatic polypeptide inhibits insulin release in the rat. Biochem Biophys Res Commun 101: 189–193.

    Article  PubMed  CAS  Google Scholar 

  8. Adrian TE, Besterman HS, Mallinson CN, Greenberg GR, Bloom SR (1979) Inhibition of secretin stimulated pancreatic secretion by pancreatic polypeptide. Gut 20: 37–40.

    Article  PubMed  CAS  Google Scholar 

  9. Gates RJ, Lazarus NR (1977) The ability of pancreatic polypeptide ( APP and BPP) to return to normal the hyperglycemia, hyperinsulinemia and weight gain of New Zealand obese mice. Horm Res 8: 189–202.

    Google Scholar 

  10. Kalk WJ, Vinik AI, Bank S, Buchanan KD, Keller P, Jackson WP (1974) Glucagon responses to arginine in chronic pancreatitis. Diabetes 23: 257–263.

    PubMed  CAS  Google Scholar 

  11. Kloppel G, Bommer G, Commandeur G, Heitz P (1978) The endocrine pancreas in chronic pancreatitis. Immunocytochemical and ultrastructural studies. Virchows Arch 377: 157–174.

    Google Scholar 

  12. Donowitz M, Hendler R, Spiro HM, Binder HJ, Felig P (1975) Glucagon secretion in acute and chronic pancreatitis. Ann Intern Med 83: 778–781.

    PubMed  CAS  Google Scholar 

  13. Mee AS, Klaff LJ, Girdwood AH, Paul M, Tyler M, Marks IN (1983) Comparative study of pancreatic polypeptide (PP) secretion, endocrine and exocrine function, and structural damage in chronic alcohol-induced pancreatitis ( CAIP ). Gut 24: 642–647.

    Google Scholar 

  14. Valenzuela JE, Taylor IL, Walsh JH (1979) Pancreatic polypeptide response in patients with chronic pancreatitis. Dig Dis Sci 24: 862–864.

    Article  PubMed  CAS  Google Scholar 

  15. Nealon WH, Beauchamp RD, Townsend CM Jr, Boyd G, Shabot M, Thompson JC (1986) Diagnostic role of gastrointestinal hormones in patients with chronic pancreatitis. Ann Surg 204: 430–437.

    Article  PubMed  CAS  Google Scholar 

  16. Inoue K, Tobe T, Suzuki T, Hosotani R, Kogire M, Fuchigami A, Miyashita T, Tsuda K, Seino Y (1986) Plasma cholecystokinin and pancreatic polypeptide response after radical pancreatoduodenectomy with Billroth I and Billroth II type of reconstruction. Ann Surg 206: 148–154.

    Article  Google Scholar 

  17. Sun YS, Brunicardi FC, Druck P, Walfisch S, Berlin SA, Chance RE, Gingerich RL, Elahi D, Andersen DK (1986) Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide. Am J Surg 151: 130–140.

    Article  PubMed  CAS  Google Scholar 

  18. Insel PA, Liljenquist TE, Tobin JD, Sherwin RS, Watkins P, Andres A, Berman M (1975) Insulin control of glucose metabolism in man: A new kinetic analysis. J Clin Invest 55: 1057–1066.

    Google Scholar 

  19. Steele R (1959) Influences of glucose loading and injected insulin on hepatic glucose output. Ann NY Acad Sci 82: 420–430.

    Article  PubMed  CAS  Google Scholar 

  20. Radziuk J, Norwich KH, Vranic M (1974) Measurement and validation of nonsteady turnover rates with applications to the inulin and glucose systems. Fed Proc 33: 1855–1864.

    PubMed  CAS  Google Scholar 

  21. DeFronzo RA, Simonson RD, Ferrannini E (1982) Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetalogia 23: 313–319.

    Article  CAS  Google Scholar 

  22. Brunicardi FC, Chaiken RL, Ryan AS, Seymour NE, Hoffmann JA, Lebovitz HE, Chance RE, Gingerich RL, Andersen DK, Elahi D (1996) Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab 81: 3566–3572.

    Article  PubMed  CAS  Google Scholar 

  23. Seymour NE, Brunicardi FC, Chaiken RL, Lebovitz HE, Chance RE, Gingerich RL, Elahi D, Andersen DK (1998) Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man. Surgery 104: 119–129.

    Google Scholar 

  24. Malaisse-Lagae F, Stefan Y, Cox J, Perrelet A, Orci L (1979) Identification of a lobe in the adult human pancreas rich in pancreatic polypeptide. Diabetologia 17: 361–365.

    Article  PubMed  CAS  Google Scholar 

  25. Adrian TE, Bloom SR, Bryant MG, Polak JM, Heitz PH, Barnes Ai (1976) Distribution and release of human pancreatic polypeptide. Gut 17: 940–944.

    Article  PubMed  CAS  Google Scholar 

  26. Nguyen TD, Wolfe MS, Heintz GG, Whitcomb DC, Taylor IL (1992) High affinity binding proteins for pancreatic polypeptide on rat liver membranes. J Biol Chem 267: 9416–9421.

    PubMed  CAS  Google Scholar 

  27. Whitcomb DC, Taylor IL, Vigna SR (1990) Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain. Am J Physiol 259: G687 - G691.

    PubMed  CAS  Google Scholar 

  28. Prillaman HM, Cox SB, Freedlender AE, Cornett GE, Jones HA, Flanagan TL, Chance Re, Hoffmann JA, Andersen DK, Elahi D, Hanks JB (1992) The effect of pancreatic polypeptide on glucose disposal after surgical alterations of the pancreas. Ann Surg 216: 574–582.

    Article  PubMed  CAS  Google Scholar 

  29. Pillion DJ, Kim SJ, Kim H, Meezan E (1992) Insulin signal transduction: the role of protein phosphorylation. Am J Med Sci 303: 40–52.

    Article  PubMed  CAS  Google Scholar 

  30. Goldfine ID (1987) The insulin receptor: molecular biology and transmembrane signaling. Endocr Rev 8: 235–255.

    Article  PubMed  CAS  Google Scholar 

  31. Soll AH, Kahn CR, Neville DM Jr, Roth J (1975) Insulin receptor deficiency in genetic and acquired obesity. J Clin Invest 56: 769–780.

    Article  CAS  Google Scholar 

  32. Kahn CR (1980) Role of insulin receptors in insulin-resistant states. Metabolism 29: 455–466.

    Article  PubMed  CAS  Google Scholar 

  33. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm GL (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79: 1330–1337.

    Article  PubMed  CAS  Google Scholar 

  34. Kern P, Picard J, Caron M, Veissiere D (1975) Deceased binding of insulin to liver plasma membrane receptors in hereditary diabetic mice. Biochem Biophys Acta 389: 281–289.

    Article  PubMed  CAS  Google Scholar 

  35. Taylor SI, Hedo JA, Underhill LH, Kasuga M, Elders MJ, Roth J (1982) Extreme insulin resistance in association with abnormally high binding affinity of insulin receptors from a patient with leprechaunism: evidence for a defect intrinsic to the receptor. J Clin Endocrinol Metab 55: 1108–1113.

    Article  PubMed  CAS  Google Scholar 

  36. Seymour NE, Volpert AR, Lee EL, Andersen DK, Hernandez C (1995) Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide. Am J Surg 169: 105–110.

    Article  PubMed  CAS  Google Scholar 

  37. Mundlos S, Adler G, Schaar M, Koop I, Arnold R (1986) Exocrine pancreatic function in oleic acid-induced pancreatic insufficiency in rats. Pancreas 1: 29–36.

    Article  PubMed  CAS  Google Scholar 

  38. Seymour NE, Volpert AR, Inman LR, Lee EL, Brunicardi FC (1995) Abnormal pancreatic polypeptide and somatostatin immunostaining in experimental chronic pancreatitis. Gastroenterology 108: A390 (Abstract).

    Article  Google Scholar 

  39. Seymour NE, Turk JB, Laster MK, Tanaka Y, Rosenberg HE, Rademaker EA, Pochettino A, Andersen DK (1989) In vitro hepatic insulin resistance in chronic pancreatitis in the rat. J Surg Res 46: 450–456.

    Article  PubMed  CAS  Google Scholar 

  40. Cuatrecasas P (1973) Interaction of concanavalin A and wheat germ agglutinin with the insulin receptor of fat cells and liver. J Biol Chem 248: 3528–3534.

    PubMed  CAS  Google Scholar 

  41. Andersen DK, Ruiz CL, Dong X, Hull EC, Seymour NE, Burant CF (1994) Rapid hormone-induced changes in hepatic insulin (INS) binding are impaired in chronic pancreatitis (CP). Dig Dis Sci 39: 1741 (Abstract).

    Google Scholar 

  42. Andersen DK, Seymour NE, Wong HC, et al. (1996) Pancreatic polypeptide (PP) immunodeficiency reproduces the altered hepatic glucose responses of chronic pancreatitis. Regul Pept 64: 3 (Abstract).

    Google Scholar 

  43. Olefsky J, Bacon VC, Baur S (1976) Insulin receptors of skeletal muscle: specific insulin binding sites and demonstration of decreased numbers of sites in obese rats. Metabolism 25: 179–191.

    Article  PubMed  CAS  Google Scholar 

  44. Soll AH, Goldfine ID, Roth J, Kahn CR (1974) Thymic lymphocytes in obese (ob/ob) mice. A minor of the insulin receptor defect in liver and fat. J Biol Chem 249: 4127–4131.

    Google Scholar 

  45. Gettys TW, Garcia R, Savage K, Whitcomb DC, Kanayama S, Taylor IL (1998) Insulin-sparing effects of pancreatic polypeptide in congenitally obese rodents. Pancreas 6: 46–53.

    Article  Google Scholar 

  46. Seymour NE, Volpert AR, Andersen DK (1996) Regulation of hepatic insulin receptors by pancreatic polypeptide in fasting and feeding. J Surg Res 65: 1–4.

    Article  PubMed  CAS  Google Scholar 

  47. Goldstein BJ, Dudley AL (1990) The rat insulin receptor: primary structure and conservation of tissue-specific alternative messenger RNA splicing. Mol Endocrinol 4: 235–244.

    Article  PubMed  CAS  Google Scholar 

  48. Seino S, Bell GI (1989) Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 159: 312–316.

    Article  PubMed  CAS  Google Scholar 

  49. McClain DA (1991) Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol Endocrinol 5: 734–739.

    Article  PubMed  CAS  Google Scholar 

  50. Balage M, Grizard J, Sornet C, Simon J, Dardevet D, Manin M (1990) Insulin binding and receptor tyrosine kinase activity in rat liver and skeletal muscle: effect of starvation. Metabolism 39: 366–373.

    Article  PubMed  CAS  Google Scholar 

  51. Carpentier J-L, Gazzano H, Van Obberghen EV, Fehlmann M, Freychet P, Orci L (1986) Intracellular pathway followed by the insulin receptor covalently coupled to 1251-photoreactive insulin during internalization and recycling. J Cell Biol 102: 989–996.

    Article  PubMed  CAS  Google Scholar 

  52. Fehlmann M, Morin O, Kitabgi P, Freychet P (1981) Insulin and glucagon receptors of isolated rat hepatocytes: Comparison between hormone binding and amino acid transport stimulation. Endocrinology 109: 253–261.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Seymour, N.E., Andersen, D.K. (1999). Pancreatic Polypeptide and Glucose Metabolism. In: Greeley, G.H. (eds) Gastrointestinal Endocrinology. Contemporary Endocrinology, vol 8. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-695-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-695-9_13

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-054-0

  • Online ISBN: 978-1-59259-695-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics